Corporate
Novartis was incorporated on March 7, 1996. This was a result of a merger between Ciba-Geigy & Sandoz, both Swiss-based pharmaceutical giants. It was the largest corporate merger at that time. Novartis is a world leader who innovates medicines to ensure protection of health, disease cure, as well as improvement of well-being.Novartis International AG celebrated its 10th anniversary in the year 2006.
Novartis International AG is a Fortune 500 Company. Novartis is the holding company of Gerber, which is an important player in the field of baby food and baby care industry. This division was sold to Nestle on 12th April, 2007.
Activities
Pharmaceuticals The Pharmaceutical Division of Novartis is a world leader which discovers, develops, manufactures, and markets prescription medicine.
Vaccines and Diagnostics Over 20 viral and bacterial diseases can be prevented by using the products of Novartis.
Sandoz Generics Sandoz is a subsidiary of Novartis International AG and it is a leader in global supply of generic pharmaceuticals. Sandoz is involved in developing, producing, and marketing generic pharmaceuticals together with pharmaceutical and biotechnological active substances.
Consumer Health
The focus of Novartis Consumer Health is to create, develop, and manufacture a wide variety of competitive products that help in restoring, maintaining, or improving the health or well-being of people.The products of Novartis include:
Pharmaceuticals: In 7 different therapeutic fields, Novartis produces over 40 general and specialty prescription medicines.
Vaccines and Diagnostics: Novartis Vaccines has a wide range of conventional products and innovative vaccines to fight bacterial and viral diseases across the world.
Sandoz: Sandoz pharmaceuticals include retail anti-infectives, generic, and biopharmaceuticals and they are usually generic bioequivalents of innovative branded products.
Animal Health: In order to ensure healthy living, a large number of products is offered by Novartis for farm animals and pets.
Over the Counter: To prevent ailments and medical conditions, Novartis OTC offers self-medication products for in-home treatment.
CIBA Vision: Ciba Vision is constantly working on contact lens care products and state-of-the-art contact lenses in order to enhance, protect, and maintain/preserve your eyesight.
Medical Nutrition: A wide range of oral nutrition brands, devices, and tubes is produced by Novartis Medical Nutrition. These can be used independently at home or in healthcare delivery settings.
Gerber: For four generations, one of the most trusted names in baby food and baby care is Gerber.
Performance
The Group Net Sales for the year ended 31-12-2006 amounted to $ 37,020 million compared to $ 32,212 million for the year ended 31-12-2005, which shows a 15% increase.The Group Net Income for the year ended 31-12-2006 amounted to $ 7202 million compared to $ 6141 million for the year ended 31-12-2005, which shows a 17% increase.
In the year 2006, total assets held by the company amounted to $ 68,008 million compared to $ 57,732 million for the year 2005.
Organization
Representative: Daniel Vasella, M.D., Chairman & Chief Executive Officer No of Employees: 98,788Address:
CH-4002 Basel, Switzerlandwww.novartis.com
